baber/WOPTO huggingface dataset:
Patent FI-20060479-A0 (FI)
Inventor: CAMPBELL ALISTAIR
IPC: H04W8/24
Filed: 2006-05-15
Abstract: Methods and apparatus are provided for a remote user to request access to a central system and for an access request to be authenticated, and for a user record to be updated. User equipment sends a pre-access request including a plurality of unique identifiers including a communications network identity identifier associated with the user equipment and a user equipment identifier. It is then determined whether any one of the unique identifiers relates to an existing user record, and a response message is sent to the remote user equipment including an indicator of the result of the determining step. The user equipment then sends an access request which includes a set of user credentials relating to a stored user record. These received user credentials are used to retrieve a user record and to determine the validity of the received user credentials. The user credentials can be authenticated as being from the user equipment by confirming whether the pre-access request was received from the same user. An authentication result message is then transmitted to the user equipment in response to authenticating the access request. The user equipment then sends an update message which requests an update of a user record.
Patent IL-100855-A0 (IL)
Title: Oxime ethers,their manufacture and their use as fungicides
IPC: A01N37/50
Filed: 1992-02-03
Abstract: alpha -Imino oxime cpds, described as oxime ethers, of formula (I) are new: R = CR2R3R4 or opt. substd. 3-8C cycloalkyl, 2-8C alkenyl, 2-8C alkynyl, phenyl or heteroaryl; R1 = H or 1-8C alkyl; R2 = H, 1-8C alkyl, aralkyl, heteroarylalkyl, alkoxyalkyl, aryloxyalkyl, aryl or heteroaryl; R3 = H, Me, CN, COOH or 2-9C alkoxycarbonyl; R4 = a gp. as defined for R2; or CR2R3 is a 5- to 8-membered lactone ring or CR2R4 is a 3-8C cycloalkane ring; R5 = H, 1-8C alkyl, aralkyl, 3-6C cycloalkyl, OH, 1-4C alkoxy, NH2, 1-4C alkylamino or dialkylamino; Y = a gp. stated to be an opt. substd. 1-8C alkyl, opt. substd. 2-8C alkenyl, 2-8C alkynyl, O, S(O)m (m = 0-2), N substd. by opt. substd. 1-8C alkyl, oxycarbonyl, carbonyloxy, oxycarbonyl (1-8C) alkyl, carbonyloxy (1-8C) alkyl, 2-8C oxyalkyloxy, 2-8C oxyalkenyl, 1-8C alkoxy, 1-4C oxyalkyl, 1-8C thioalkyl, azo, opt. 1-8C alkyl-substd. -carbonylamino, -aminocarbonyl or -aminocarbonyloxy, oxyimino or opt. substd. imino oxyalkyl; Z = (a) 1-18C alkyl, 2-18C alkenyl, 3-18C alkynyl, aryl, aryl (1-10C) alkyl, aryl (2-10C) alkenyl, aryloxy (1-10C) alkyl, (1-4C) alkoxy (1-10C) alkyl, 1-10C haloalkyl, 2-5C alkoxycarbonyl or heteroaryl; (b) aryloxy, aryloxy (1-10C) alkoxy, aryl (1-10C) alkoxy, 1-10C alkoxy or heteroaryloxy when Y is not oxyalkyl, oxyalkyloxy, thialkyl (sic), -O-N=C- (sic), -N=N-, oxycarbonyl, oxycarbonyloxy, O or S; or (c) 1-18C alkylthio or arylthio when Y is not oxyalkyl, oxyalkyloxy, -O-N=C- (sic), -N=N-, oxycarbonyl, oxycarbonyloxy or O, and Z is opt. substd. by halogen, CN, NO2, 1-4C alkyl, 2-4C alkenyl, 1-4C alkoxy, 1-4C haloalkyl, (1-4C) alkoxy (1-4C) alkyl, di(1-4C) alkoxy (1-4C) alkyl, opt. substd. 1-10C alkoxyimino, opt. substd. 2-10C alkenyloxyimino, opt. substd. aralkoxyimino, opt. substd. 2-10C alkanoyl, opt. substd. formyl, 2-4C haloalkenyl, 2-5C alkoxycarbonyl, opt. substd. phenyl, or opt. substd. 5-membered heterocyclyl which contains 1-4 heteroatoms (N, O and/or S) and is opt. fused with an opt. substd. aromatic or heteroaromatic ring; X = H, halogen, NO2 and/or opt. substd. 1-4C alkyl, 1-4C alkoxy and/or 1-4C haloalkyl; m = 1-4.
Patent IL-102759-A0 (IL)
Title: Hydantoin derivatives,their preparation and pharmaceutical compositions containing them
IPC: A61P7/02
Filed: 1992-08-07
Abstract: The present invention relates to hydantoin derivatives of the general formula I <IMAGE> in which Y and R<1> to R<4> are defined as indicated in claim 1, process for the preparation thereof and the use thereof for inhibiting platelet aggregation.
Patent IL-107394-A0 (IL)
Title: Processes for the preparation of metal complexes of tetraazacycloalkane derivatives
IPC: C07D257/02
Filed: 1993-10-25
Abstract: A novel process is described for the preparation of metal complexes of N- beta -hydroxyalkyl-tri-N-carboxyalkyl-1,4,7,10-tetraazacyclo-dodecane and N- beta -hydroxyalkyl-tri-N-carboxyalkyl-1,4,8,11-tetraaza-cyclotetradecane derivatives.
Patent IL-114779-A0 (IL)
Title: Estra-1,3,5(10)-triene derivatives process for the preparation thereof and pharmaceutical compositions containing the same
Inventor: SCHWARZ SIGFRID PROF DR
IPC: A61P5/30
Filed: 1995-07-30
Abstract: 3-Sulphamoyloxy-oestra-1,3,5(10)-triene derivs. of formula (I) are new. R = NR1R2; R1, R2 = H or 1-5C alkyl; or NR1R2 = 4-6C polymethyleneimino or morpholino; R3 = H or 1-5C alkyl; R4 = H, opt. esterified OH, 1-5C haloalkyl or 1-5C alkoxy; R5, R6 = H; or R5+R6 = CH2; R7, R9 = H or OH; R8 = H, OH or 2-5C alkynyl; or R8+R9 = O or R5+R8 = CH=CH or CH2CH2; and the B ring opt. contains one or two double bonds.
Patent IL-131939-A0 (IL)
Title: Method of downloading of data to an mpeg receiver/decoder and mpeg transmission system for implementing the same
IPC: H04L9/10
Filed: 1997-04-25
Abstract: In a digital satellite television system in which a television receives its signal via a receiver/decoder, such as a set top box, interactive applications can be downloaded and run on the receiver/decoder. The application code is arranged as modules, and the downloading of modules is preceded by searching a directory module within a specified local address. The modules are signed and the directory module is signed and encrypted so that a single encryption applies to all of the modules making up the application. Multiple public encryption keys are stored in ROM in the receiver/decoder, so that applications can be created by different sources, without the sources needing to know each other's private encryption keys. A facility is provided to enable an encryption key to be temporarily stored in RAM in the receiver/decoder, so that a manufacturer of the receiver/decoder can check its functionality. A signature of the directory may be hidden at a variable position in a block of dummy data in the directory module. An application to be downloaded may be checked against an application validation bitmap stored in the receiver/decoder. <IMAGE>
Patent IL-133392-A0 (IL)
Title: Benzo (5, 6) cyclohepta (1, 2b) pyridine derivatives useful for inhibition of farnesyl protein transferase
IPC: C07D409/14
Filed: 1998-06-15
Abstract: Novel compounds of formula (1.0) are disclosed. In Formula (1.0) a represents N or NO, R<1> and R<3> are halo, R<2> and R<4> are independently H or halo provided that at least one is H, X is C, CH or N, and T represents a five or six membered heterocycloalkyl ring having one or two heteroatoms selected from S or O. Also disclosed are methods of inhibiting farnesyl protein transferase and methods for treating tumor cells.
Patent IL-135130-A0 (IL)
Title: Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient
IPC: A61K9/20
Filed: 1998-09-18
Abstract: Composition comprising a salt of dichloromethylene bisphosphonic acid (I; clodronate) and silicified microcrystalline cellulose as an oral solid dosage form, is new : Independent claims are also included for the manufacture of the oral dosage forms. ACTIVITY : Hypocalcemic.
Patent IL-149801-A0 (IL)
Title: Oligomer array with pna and/or dna oligomers on a surface
IPC: C12N15/09
Filed: 2000-11-24
Abstract: Array (A) of peptide nucleic acids (PNA) and/or DNA oligomers (I), containing 6-20 monomers or bases on a surface, with the position of each (I) being correlated with its sequence. Array (A) of peptide nucleic acids (PNA) and/or DNA oligomers (I), containing 6-20 monomers or bases on a surface, with the position of each (I) being correlated with its sequence. Each (I) includes at least one of the sequences DDCGDD (Ia), DDTGDD (Ia), HHCGHH (Ia) or HHCAHH (Id) H : one of adenine (A), C or T; and D : one of A, G and T.
Patent IL-158611-A0 (IL)
Title: Method and apparatus for interoperation between legacy software and screen reader programs
IPC: G06F9/44
Filed: 2002-03-11
Abstract: A computer program for facilitating operation of a screen reader with legacy programs whose user interface definitions do not conform to the design guidelines expected by the screen reader program. A graphical user interface is analyzed to identify a logical sequence of user interface elements within the interface. The sequence of user interface elements within a definition of the user interface is compared with the identified logical sequence to identify any required reordering of the elements to conform to the identified logical sequence. One or more lists or tables are generated for each separable user interface component to (1) specify the required sequence for reordering incorrectly-sequenced user interface controls within the definition and to (2) identify a new static text control which is dynamically generated for use with an edit control which does not have a required static text control.
Patent IL-162070-A0 (IL)
Title: Fluid drug delivery device
IPC: A61M5/145
Filed: 2002-11-26
Abstract: A portable insulin delivery device that supplies insulin in a pre-pressurized chamber, passes the insulin through a pressure-dropping labyrinth to a flow control valve. The valve is activated by a piezoelectric actuator. This allows for precise insulin delivery. An electronic package provides for programming of basal rates and bolus. A pressure sensor relays data concerning normal operation and pressure changes that indicate problems. The processor, keypad, displays power source, fluid pressure sensor and fluid flow control actuator are housed in a base unit. A removable cartridge unit houses the pre-pressurized fluid reservoir, flow path labyrinth, and flow control valve.
Patent IL-162787-A0 (IL)
Title: Direct conversion with variable amplitude lo signals
IPC: H04B1/30
Filed: 2003-11-14
Abstract: Techniques to reduce LO leakage by controlling the amplitude of LO signal based on the level of output signal after the frequency conversion process. An LO generator receives a VCO signal and generates an LO signal having a variable amplitude and a frequency that is related to the frequency of the VCO signal. A variable gain amplifier receives a control signal and adjusts the amplitude of the LO signal based on the control signal. The variable amplitude LO signal is used for frequency upconversion (e.g., direction upconversion) of an input signal (e.g., at baseband) to obtain an output signal (e.g., at RF). The relationship between LO signal amplitude and output signal level may be defined by a particular transfer function. In general, the LO signal is set higher for higher output signal level and is reduced proportionally for lower output signal level.
Patent IL-165918-A0 (IL)
Title: Improved transdermal delivery system for the administration of rotigotine
IPC: A61P25/16
Filed: 2004-12-22
Abstract: An improved Transdermal Delivery System (TDS) comprising a backing layer inert to the components of the matrix, a self-adhesive matrix containing rotigotine and a protective foil or sheet to be removed prior to use, characterized in that the self-adhesive matrix consists of a solid or semi-solid semi-permeable polymer  (1) wherein rotigotine in its free base form has been incorporated, (2) which is saturated with rotigotine and contains said rotigotine as a multitude of microreservoirs within the matrix, (3) which is highly permeable for the free base of rotigotine, (4) which is impermeable for the protonated form of rotigotine, (5) wherein the maximum diameter of the microreservoirs is less than the thickness of the matrix.  is provided. Said TDS provides for enhanced flux of rotigotine across the TDS/skin interface.
Patent IL-183365-A0 (IL)
Title: Osteoprotegerin variant proteins
Filed: 2007-05-21
Abstract: The present invention relates to novel osteoprotegerin variant proteins (GYPs) that demonstrate reduced binding affinity for their ligand TRAIL when compared to wild-type osteoprotegerin. Nucleic acids which encode these GYPs are also provided. Recombinant vectors and host cells expressing these GYPs are also encompassed as are methods of producing recombinant GYPs. The present invention also relates to compositions comprising these GYPs, and to methods of treating bone diseases characterised by increased bone turnover and/or loss. The GYPs of the invention are useful for preventing bone resorption and may be used to treat any condition resulting in abnormal bone turnover or bone loss such as osteoporosis, hypercalcemia, Paget's disease of bone, multiple myeloma, bone cancer and bone loss due to rheumatoid arthritis or osteomyelitis, and the like.
Patent RO-125907-A0 (RO)
Title: Complex compressed air installation - incomac 0 - for the control of beach erosion and reducing the surfaced covered by the black sea, for making and superelevating dikes on internal rivers and danube, for preventing floods and for fast and safely carrying out urban and rural public works
Inventor: ROMAN IOAN
IPC: E02B3/06
Filed: 2010-08-11
Abstract: The invention relates to a compressed air installation employed in the field of hydrotechnics and urban and rural public works. According to the invention, the installation consists of at least one module comprising two plane metal panels (2) carried out on a metal structure consisting of two longitudinal metal profiles (20), a longitudinal profile (34) and six vertical metal profiles (21) welded to one another, inside of each metal panel (2) there being mounted three squared pipes (18), with a view to positioning the panels (2) in the vertical position by means of a handling frame (10), each of the panels (2) being provided inside with some pressure pipes (9), and at their base, with an acting-dislocation cone (4) which is provided allover its surface with some holes (30), said cone (4) being connected to some pressure pipes (24) located inside the panels (2), the pressure pipes (9 and 24) being in connection with a compressed air station (8).
Patent RO-129717-A0 (RO)
Title: Process for manufacturing thermally insulating and dense refractory concrete based on silico-calcic cements with high initial resistance
Inventor: GHIŢĂ VASILE
IPC: C04B14/02
Filed: 2013-05-21
Abstract: The invention relates to a process for manufacturing thermally insulating and dense refractory concrete. According to the invention, the process consists in mixing, with homogenization, 25% silico-calcic cement with mechanical resistance to compression of minimum 40MPa at 28 days and loss during calcination of maximum 5%, and 75% refractory granular aggregates of silico-aluminous fire clay type, wherefrom there results a concrete mixture with a usage temperature of 1000...1200°C.
Patent AP-2000001756-A0 (AP)
Title: System for selectively downloading information at user terminals from the internet using a satellite broadcast system.
Inventor: CAMPANELLA JOSEPH S
IPC: H04N21/647
Filed: 1998-08-19
Abstract: A satellite direct digital broadcast system is provided which broadcasts selected internet information such as new reports, weather reports and stock market rates, along with radio programs. Broadcast channels comprise internet information and a service control header to identify the type of internet information contained therein. User terminals (22)are provided which comprise a radio broadcast receiver (2)to receive programs broadcast via satellite (20). Audio programs are played on a speaker connected to a radio broadcast receiver (21). The user terminals (22)also comprise a multimedia device such as a personal computer (29)connected to the receiver. The multimedia device is programmed to generate a computer display which prompts a user to select a selectively retrieves packets to generate displays such as web pages using those packets which correspond to the topic of information selected by the user.
Patent IE-900883-A1 (IE)
Title: "Sanitaryware"
Inventor: BYRNE THOMAS
IPC: B28B1/26
Filed: 1990-03-13
Abstract: A vanity stand 1 includes a washbasin 4 mounted in a recess in the countertop 3. The basin 4 is cast from ceramic material in a mould 21, 22. A saddle tool 30 is used to support the 5 basin 4 during removal from the mould. The basin 4 is then placed On a flat setter member 40 having a distortion counteracting pad 45 of elastomeric material which ensures that the rim 6 of the basin 4 during setting distorts in a manner which ensures that when fitted to a recess in a vanity 10 stand the underside 7 of the rim of the basin remains substantially flat for flush mounting. After drying and glazing the basins are fired in a kiln.
Patent LU-92847-A1 (LU)
Title: Une construction habitable avec les papiers de format A4
Inventor: AGHAJANI MAJID
IPC: E04B7/00
Filed: 2015-10-09
Abstract: La construction habitable en papier recyclé format A4 et les autres, procédé tous les éléments essentiels pour une construction (les Fig. 1-12) et le réassemblage ces éléments pour réaliser cette construction bien adapté cotre séisme, le coup, le cisaille et isolante thermique, phonique et acoustique.
Patent MA-27490-A1 (MA)
Title: Formulation d'ibuprofene sodique.
Inventor: PETER GRUBER
IPC: A61P29/00
Filed: 2005-05-09
Abstract: Comprimé non effervescent d'ibuprofène. comprenant un comprimé nu et, si on le souhaite, une dragéification ou un pelliculage, dans lequel le comprimé nu se compose de 50 à 100% en poids d'hydrate d'ibuprofène sodique et de 50 à 0% en poids d'adjuvant, sur la base du poids du comprimé nu. et ne contient ni lubrifiant ni agent de délitement, l'hydrate d'ibuprofène sodique ayant une teneur en eau allant de 8 à 16%, de préference de 11 à 16% en poids, qui possède une dureté suffisante, qui est d'une taille relativement petite et mène à une augmentation particulièrement rapide des concentrations sanguines et, par conséquence, a un début accéléré de l'effet analgésique. Contrairement à l'opinion reçue, l'hydrate d'ibuprofène sodique ayant une teneur en eau appropriée est suffisamment compressible.
Patent MA-39450-A1 (MA)
Title: Sels pharmaceutiquement acceptables d'énantiomères de pirlindole s'utilisant en médecine
Inventor: PARDAL FILIPE AUGUSTO EUGÉNIO
IPC: A61P25/24
Filed: 2014-05-09
Abstract: L'invention concerne des sels pharmaceutiquement acceptables de composés de (r)-pirlindole et de (s)-pirlindole énantiomériquement purs, qui présentent un profil de biodisponibilité acrrue et se destinent à un usage médical.
Patent MA-41532-A1 (MA)
Title: Procédé de dessalement par humidification-déshumidification alimenté par une centrale thermo-solaire à concentration à tour
Inventor: ZEJLI Driss
IPC: C02F1/04
Filed: 2017-11-24
Abstract: Le présent brevet concerne un procédé de cogénération d'énergie électrique et d'eau douce via respectivement une tour solaire et un système de dessalement par humidificationdéshumidification, le principe consiste en la récupération de la chaleur de l'air de retour de la tour solaire et son utilisation pour l'alimentation en air chaud d'un distillateur à humidification - déshumidification. Cet air de retour doté d'une température de près de 300°c est d'tille humidité relative tellement faible que sa capacité à s'humidifier est importante. Son utilisation, dans un distillateur à humidification-déshumidification, produit de l'eau douce nécessaire au fonctionnement de la centrale solaire à tour utilisant le cycle de refroidissement humide, dans une région aride ou semi-aride où l'eau douce est rare ou fait défaut et où de l'eau saumâtre ou de mer pourrait abonder.
Patent MA-46155-A1 (MA)
Title: Dispositif et procédé d'insémination artificielle
Inventor: PLESSALA KIRBY
IPC: A61M31/00
Filed: 2017-11-30
Abstract: La présente invention concerne un dispositif médical et un procédé pour l'insémination artificielle. Le dispositif médical comporte un écran de protection et un bras fixé à l'écran au niveau d'une extrémité et s'étendant vers l'extérieur à partir de l'écran. Le bras est inséré dans le canal cervical d'une patiente et l'écran recouvre les os externes du patient. En insérant le dispositif médical dans le canal cervical d'une patiente après l'insémination, une barrière physique qui maintient un échantillon de sperme à l'intérieur du canal cervical et empêche une fuite du canal cervical dans la cavité vaginale est établie. Le dispositif peut avoir un alésage s'étendant à travers le dispositif pour qu'un cathéter passe à travers celui-ci. L'alésage a une valve pour permettre le passage du cathéter et empêcher le retour de sperme. Le bras peut avoir un renflement circonférentiel pour aider à maintenir le dispositif en place pendant l'utilisation.
Patent UY-23679-A1 (UY)
Inventor: ROFFMAN JEFFREY H
IPC: G02C7/06
Filed: 1993-12-08
Abstract: A pair of ophthalmic lenses both containing at least two optical powers, one for near vision and one for distance vision are described, both containing in the center portion of the lens the distance optical power. In the preferred embodiment, the remainder of the lens is comprised of annular portions made up of one or more optical zones to provide the desired combined, cumulative ratio of near and distance focal length areas at each pupil diameter. The distance portion located in the center is appropriately suited to the real world situation of requiring distance vision under high illumination situations.
Patent UY-24897-A1 (UY)
Title: (s) - atropisomeros de 3-aril-4(3h)-quinazolinonas
Inventor: DEVRIES KEITH MICHAEL
IPC: C07D413/06
Filed: 1998-02-20
Abstract: Atropisómeros (S) con relación al carbono marcado con el asterisco, de fórmula (Ia) representada en la figura 1, y sus sales farmacéuticamente aceptables en donde: R2 es un heterociclo de 5 o 6 miembros, representado en la figura 2; las posiciones "K", "L", y "M" en dicho anillo pueden estar seleccionadas de manera independiente de entre carbono o nitrógeno; R3 es hidrógeno o halo; R5 es halo; R6, R7 y R8 son hidrógeno. Ejemplos no limitantes de compuestos preferidos: (S)-3-(2-cloro-fenil)-2-[2-(5-dimetilaminometil-2-fluoro-fenil)-vinil]-6-fluoro-3H-quinazolin-4-ona; (S)-6-fluoro-2-[2-(2-metil-tiazol-4-il)-vinil]-3-(2-metil-fenil)-3H-quinazolin-4-ona. Una composición farmacéutica de estos compuestos son de utilidad en el tratamiento de afecciones neurodegenerativas y relacionadas con traumas del SNC, como también para prevenir una afección seleccionada entre déficits cerebrales posteriores o resultantes de una cirugía de desviación cardíaca e injertos.
Patent UY-25055-A1 (UY)
Title: Formulaciones farmacéuticas que contienen voriconazol
Inventor: HARDING VALERIE DENISE
IPC: A61K31/505
Filed: 1998-06-19
Abstract: Formulación farmacéutica que comprende voricozanol, o un derivado farmacéuticamente aceptable del mismo y un derivado de ciclodextrina. . Este compuesto es útil en el tratamiento de infecciones fúngicas. El voriconazol tiene baja estabilidad en agua y no es estable en ella. Asi pues, es difícil el desarrollo de una formulación intravenosa acuosa, con suficiente duración útil de almacenamiento. Asi pues , de acuerdo a la presente invención se proporciona una formulación farmacéutica que es voriconazol o un derivado farmacéuticamente aceptable y un derivado de ciclodextrina La estabilidad acuosa del complejo voriconazol-derivado de ciclodextrina se incrementa por la liofilización